Cite
McCulloch D, Brown C, Iland H. Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives. Onco Targets Ther. 2017;10:1585-1601doi: 10.2147/OTT.S100513.
McCulloch, D., Brown, C., & Iland, H. (2017). Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives. OncoTargets and therapy, 101585-1601. https://doi.org/10.2147/OTT.S100513
McCulloch, Derek, et al. "Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives." OncoTargets and therapy vol. 10 (2017): 1585-1601. doi: https://doi.org/10.2147/OTT.S100513
McCulloch D, Brown C, Iland H. Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives. Onco Targets Ther. 2017 Mar 14;10:1585-1601. doi: 10.2147/OTT.S100513. eCollection 2017. PMID: 28352191; PMCID: PMC5359123.
Copy
Download .nbib